These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36401407)

  • 1. Effectiveness of Sopoongsan for chronic upper body pruritus in patients with atopic or seborrheic dermatitis: A pilot study protocol for a randomized, double-blind, placebo-controlled, parallel trial.
    Jang JH; Jun P; Park G; Kwon O; Choi Y; Lim HS; Moon BC; Kim K
    Medicine (Baltimore); 2022 Nov; 101(46):e31470. PubMed ID: 36401407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders: Study protocol of a double-blind randomized placebo-controlled trial.
    Kang SJ; Cho HB; Jo EH; Yang GJ; Hong JE; Lee JH; Shim YH; Mun JH; Park MC
    Medicine (Baltimore); 2020 Jan; 99(2):e18565. PubMed ID: 31914034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
    Kabashima K; Matsumura T; Komazaki H; Kawashima M;
    N Engl J Med; 2020 Jul; 383(2):141-150. PubMed ID: 32640132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of an herbal formula, Gwakhyangjeonggi-san on atopic dermatitis with gastrointestinal symptoms: Protocol for a randomized controlled trial.
    Son MJ; Kim MH; Kang M; Kim YE; Jung J; Choi I
    Medicine (Baltimore); 2020 Jul; 99(28):e20675. PubMed ID: 32664064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Soshiho-tang in patients with atopic dermatitis and gastrointestinal disorders: Study protocol for a double-blind, randomized, and placebo-controlled clinical trial.
    Kang SJ; Jo EH; Yang GJ; Shim YH; Hong JE; Park MC
    Medicine (Baltimore); 2019 May; 98(18):e15479. PubMed ID: 31045830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Bojungikgi-tang on anorexic patients with atopic dermatitis: A protocol for a randomized, usual care-controlled, assessor-blinded, parallel, pilot clinical trial.
    Lee B; Park HJ; Jung SY; Kwon OJ; Ko MM; Jeong HA; Jung J
    Medicine (Baltimore); 2022 Mar; 101(9):e28965. PubMed ID: 35244061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
    Simpson EL; Bieber T; Guttman-Yassky E; Beck LA; Blauvelt A; Cork MJ; Silverberg JI; Deleuran M; Kataoka Y; Lacour JP; Kingo K; Worm M; Poulin Y; Wollenberg A; Soo Y; Graham NM; Pirozzi G; Akinlade B; Staudinger H; Mastey V; Eckert L; Gadkari A; Stahl N; Yancopoulos GD; Ardeleanu M;
    N Engl J Med; 2016 Dec; 375(24):2335-2348. PubMed ID: 27690741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
    Murata Y; Song M; Kikuchi H; Hisamichi K; Xu XL; Greenspan A; Kato M; Chiou CF; Kato T; Guzzo C; Thurmond RL; Ohtsuki M; Furue M
    J Dermatol; 2015 Feb; 42(2):129-39. PubMed ID: 25491792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial.
    Tsianakas A; Luger TA; Radin A
    Br J Dermatol; 2018 Feb; 178(2):406-414. PubMed ID: 28845523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for chronic pruritus of unknown origin.
    Andrade A; Kuah CY; Martin-Lopez JE; Chua S; Shpadaruk V; Sanclemente G; Franco JV
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013128. PubMed ID: 31981369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.
    Xuan M; Guo X; Li H; Xie T; Mo X; Wen Z
    Trials; 2021 Jan; 22(1):67. PubMed ID: 33468222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hwangryunhaedoktang in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial--study protocol.
    Kim NK; Lee DH; Seo HS; Sun SH; Oh YL; Kim JE; Yoon IH; Seo ES; Shim GS; Zaslawski C
    BMC Complement Altern Med; 2011 Aug; 11():68. PubMed ID: 21861896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis.
    Klein PA; Clark RA
    Arch Dermatol; 1999 Dec; 135(12):1522-5. PubMed ID: 10606058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological profiles and clinical findings of nemolizumab as treatment for pruritus associated with atopic dermatitis].
    Kaneda N
    Nihon Yakurigaku Zasshi; 2023; 158(3):282-289. PubMed ID: 37121713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Yokukansankachimpihange on sleep disturbance in Parkinson's disease: A study protocol of a randomized, double blind, placebo-controlled pilot trial.
    Jang JH; Lee J; Jung I; Yoo H
    Medicine (Baltimore); 2018 Jun; 97(26):e11298. PubMed ID: 29953013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.